YBGJ — Yubo International Biotech Ltd

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 895464 ·
Last close
$0.01
Market Cap
$937.3K
52W High
$0.02
52W Low
$0.00
ADV30
921
Next earnings
—
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound drink/beverage; and facial care, eye care, and hair care series products. Yubo International Biotech Limited is headquartered in Beijing, China.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 0 -203,388 -188,376 651,391 9,465 3,549,427
Jun 2026 0 0 -238,861 -247,949 672,272 11,989 3,327,599
Mar 2026 0 0 -289,274 -272,608 709,872 10,382 3,019,451
Dec 2025 12,353 8,165 -285,468 -261,418 847,094 8,062 2,791,296

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-727,991
Investing CF
$-79,904
Financing CF
$667,380
CapEx
$-6,186
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-8,260,616
Inventory
$24,803
Receivables
$435,325
ST Investments
—
EBIT TTM
$-1,123,737
Pretax Income TTM
$-1,159,550
Interest Exp TTM
$35,653
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,353
EBITDA
$-940,123
Free Cash Flow
$208,403
Enterprise Value
$2,557,641
Total Cash
$9,465
Total Debt
$1,677,878
Shares Out
170,416,343
Trailing EPS
$0.00
Book Value
$-0.02
ROE
—
ROA
-79.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 12,353 -1,187,696 -1,079,248 847,094 2,791,296 -1,954,656 -842,802
Dec 2024 3,470 -1,769,919 -1,775,303 1,534,831 4,832,522 -3,424,465 -1,337,729
Dec 2023 604,676 -1,194,706 -1,195,083 1,667,269 3,510,972 -1,843,703 -738,971
Dec 2022 104,283 -1,205,223 -1,204,994 2,348,551 2,913,924 -565,373 -600,953
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$12,353
NetIncome TTM
$-933,842
OpCashFlow TTM
—
Assets (Latest)
$672,272
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
BTCY BIOTRICITY INC. $910.1K $0.05 —
VJET Flyte Aviation, Inc. $890.2K $0.42 —
BBLG Bone Biologics Corp $1.05M $0.31 —
TNON Tenon Medical, Inc. $833.8K $1.25 —
ODYY Odyssey Health, Inc. $771.5K $0.01 —

Recent Insider Activity

No insider activity indexed for this ticker.